## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukinβ2, has resulted in prolonged responses in a small subset of
β¦ LIBER β¦
Immunotherapy for metastatic melanoma approved
β Scribed by Papatriantafyllou, Maria
- Book ID
- 109956506
- Publisher
- Nature Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 82 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1474-1741
- DOI
- 10.1038/nri2981
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Immunotherapy for metastatic melanoma
β
Christopher R. Zito; Harriet M. Kluger
π
Article
π
2012
π
John Wiley and Sons
π
English
β 118 KB
IMMUNOTHERAPY, INCLUDING GENE THERAPY, F
β
Michael G. E. O'Rourke; Christopher W. Schmidt; Thomas R. Oβrourke; Kay A. O. El
π
Article
π
1997
π
John Wiley and Sons
π
English
β 951 KB
Topical diphencyprone immunotherapy for
β
Diona L Damian; Kerwin F Shannon; Robyn P Saw; John F Thompson
π
Article
π
2009
π
John Wiley and Sons
π
English
β 880 KB
Adenovirus-mediated expression of melano
β
Hirschowitz, E A; Leonard, S; Song, W; Ferris, B; Leopold, P L; Lewis, J J; Bown
π
Article
π
1998
π
Nature Publishing Group
π
English
β 150 KB
Adjuvant immunotherapy for melanoma
β
L. J. Humphrey; S. Taschler-Collins; P. M. Coldfarb; O. Sincla; F. J. Volenec
π
Article
π
1984
π
John Wiley and Sons
π
English
β 282 KB
Adjuvant immunotherapy was administered to 84 lymph-node-negative and 25 lymph-node-positive melanoma patients. This active specific homologous cell protein preparation was given after aggressive surgery and given over 2 years. Projected and observed survival rates are presented as well as other cli
Betting on immunotherapy for melanoma
β
Mario Sznol
π
Article
π
2009
π
Current Science Inc.
π
English
β 298 KB